Embla Systems LLC Market Share Analysis

Publisher Name :
Date: 12-Dec-2012
No. of pages: 27

Embla Systems LLC Market Share Analysis

Summary

GlobalData’s new report, “Embla Systems LLC Market Share Analysis” provides in-depth information on Embla Systems LLC’s market position in the sleep apnea diagnostic systems market. The report also provides data and information on the overall competitive landscape within the sleep apnea diagnostic systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the sleep apnea diagnostic systems market.
- Embla Systems LLC’s company shares (in Revenues) information for all the key countries the company has presence in -Brazil, Italy, Spain, United Kingdom, Germany, China, Japan, India, Australia, United States and Canada.
- Embla Systems LLC’s company shares (in Revenues) information for the sleep apnea diagnostic systems market.
- All the key data-points are for 2011 and cover all the key regions -Europe, Asia-Pacific, North America, South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Embla Systems LLC’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Embla Systems LLC’s market positions.

Embla Systems LLC Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
3 Definitions of Markets/Categories Covered 6
3.1 Anesthesia and Respiratory Devices 6
3.1.1 Sleep Apnea Diagnostic Systems 6
4 Company Snapshot 7
4.1 Key Information 7
4.2 Company Overview 7
4.3 Major Products and Services 8
4.3.1 Overview 8
5 Competitors 9
6 Competitive Landscape 10
6.1 Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), Global, Market Share (%), 2011 10
6.2 Embla Systems LLC, Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), by Region, Market Share (2011) 12
6.3 Embla Systems LLC, Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), by Country, Market Share (2011) 13
7 Key Employees 15
8 Locations And Subsidiaries 15
8.1 Head Office 15
9 Financial Deals Landscape 16
9.1 Embla Systems LLC, Deals Volume Summary, 2006 to YTD 2012 16
10 Embla Systems LLC Detailed Deal Summary 18
10.1 Asset Purchase 18
10.1.1 Covidien Sells Sleep Diagnostics Products To Embla Systems 18
10.2 Partnerships 19
10.2.1 Embla Systems Enters Into Collaboration With Beth Israel Deaconess 19
10.3 Acquisition 20
10.3.1 Natus Medical Acquires Embla Systems For $16.1 Million 20
11 Recent Developments 21
11.1 Other Significant Developments 21
11.1.1 Apr 02, 2010: Premier Awards New Contracts For Polysomnography, Neurological Equipment And Accessories 21
12 Appendix 22
12.1 Research Methodology 23
12.2 Secondary Research 23
12.3 Primary Research 24
12.4 Models 24
12.5 Forecasts 24
12.6 Expert Panels 25
12.7 GlobalData Consulting 25
12.8 Currency Conversion 26
12.9 Contact Us 27
12.10 Disclaimer 27

1.1 List of Tables
Table 1: Embla Systems LLC, Key Information, 2011 7
Table 2: Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), Global, Company Share by Revenue ($m), 2011 11
Table 3: Embla Systems LLC, Anesthesia and Respiratory Devices, Sleep Apnea Diagnostic Systems, Global, Revenue ($m) and Market Share (%), 2011 12
Table 4: Embla Systems LLC, Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), by Country, Revenue ($m) and Market Share (%), 2011 14
Table 5: Embla Systems LLC, Key Employees 15
Table 6: Embla Systems LLC, Deals Volume Summary, 2006 to YTD 2012 16
Table 7: Embla Systems LLC, Deals Summary, 2006 to YTD 2012 17
Table 8: Covidien Sells Sleep Diagnostics Products To Embla Systems 18
Table 9: Embla Systems Enters Into Collaboration With Beth Israel Deaconess 19
Table 10: Natus Medical Acquires Embla Systems For $16.1 Million 20
Table 11: USD to Local Currency, Average Exchange Rate, 2011 26

1.2 List of Figures
Figure 1: Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), Global, Market Share (%), 2011 10
Figure 2: Embla Systems LLC, Anesthesia and Respiratory Devices, Sleep Apnea Diagnostic Systems, Global, Market Share (%), 2011 12
Figure 3: Embla Systems LLC, Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), by Country, Market Share (%), 2011 13
Figure 4: Embla Systems LLC, Deals Volume Summary, 2006 to YTD 2012 16
  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Aortic Stent Grafts – Current and Future Players
    Published: 29-Oct-2014        Price: US $3500 Onwards        Pages: 106
    Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated r......
  • Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma
    Published: 29-Oct-2014        Price: US $6995 Onwards        
    Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development across all stages, but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse range of therapies targeting multiple signaling pathways and molecules integral to cancer development. Thi......
  • Egypt Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters, increasing the attractiveness of the pharmaceutical market - for which our forecast has been revised slightly upwards. The government's increased emphasis on developing the pharmaceutical sector and the announced expansion of the Medicare healthcare programme are positive developments this quarter. The challenges faced by pharmaceutical companies wishing to operate in the market are the c......
  • Indonesia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 142
    BMI View: Indonesia is one of the most promising markets for the pharmaceutical and healthcare companies in South East Asia. The country's large population, positive economic outlook and considerable disease burden bode well for growth in demand for drugs, medical devices and healthcare services. The ongoing implementation of the universal healthcare scheme in Indonesia coupled with the impending launch of the ASEAN Economic Community will provide growth opportunities for pharmaceutical firm......
  • Moldova Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 93
    BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors, given the market's total size and its reliance on out-of-pocket payments. The country's economic outlook, which is defined by its relations with Russia and the EU, will play a significant role in how the market grows over the coming years. Headline Expenditure Projections ? Pharmaceuticals: MDL2.73bn (USD214mn) in 2013 to MDL2.9bn (USD226mn) in 2014; +5.7% in local currency terms and +5.4% in US doll......
  • Sri Lanka Pharmaceuticals and Healthcare Report Q4 2014
    Published: 29-Oct-2014        Price: US $1295 Onwards        Pages: 81
    BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notably Indian - investors in recent years, as economic growth has picked up and the government focused on improving the domestic pharmaceutical sector. We therefore expect that pharmaceutical and healthcare sector growth will outpace economic growth over the five-year forecast period. Improved relations with India, after the country abstained from voting on the UNHCR resolution, are likely to spu......
  • 2014 Deep Research Report on Global and China Nalbuphine HCL Industry
    Published: 28-Oct-2014        Price: US $2200 Onwards        Pages: 121
    This is a professional and depth research report on Global and China Nalbuphine HCL industry. The report firstly introduced Nalbuphine HCL basic information included Nalbuphine HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Nalbuphine HCL industry policy and plan, Nalbuphine HCL product specification, manufacturing process,......
  • 2014 Deep Research Report on Global and China Naltrexone HCL Industry
    Published: 28-Oct-2014        Price: US $2200 Onwards        Pages: 138
    This is a professional and depth research report on Global Naltrexone HCL industry. The report firstly introduced Naltrexone HCL basic information included Naltrexone HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Naltrexone HCL production and market shar......
  • RNA Interference Screening Trends 2014
    Published: 27-Oct-2014        Price: US $2500 Onwards        Pages: 53
    Executive Summary This market report summarizes the results of HTStec’s industry-wide global web-based benchmarking survey on RNA interference (RNAi) screening and gene silencing carried out in October 2014. The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces and to update our previous report in siRNA screening (published September 2012). The questionnaire was compiled to meet the needs, requirements and interests of the RNAi screening vendo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs